Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Technology Industry News SirionLabs secures $110m in Series D for AI-powered CLM platform SirionLabs, a Seattle-based artificial intelligence (AI)-powered contract lifecycle management (CLM) platform, has raised its Series D funding to… byRaghuram KadariJanuary 7, 2023